Leaders in Health and Human Services Reporting

^Subscribers gain full access to all of our must-have reports and videos

Leaders in Health and Human Services Reporting

^Subscribers gain full access to all of our must-have reports and videos

Health Care Reporting

Health Care Reporting

Public Health Funding and Policy Committee

Public Health Funding and Policy Committee

Hospital Payment Advisory Committee

Hospital Payment Advisory Committee

Medicaid/CHIP Market Intelligence Data Workbook

Medicaid/CHIP Market Intelligence Data Workbook

Latest Posts

Senate Committee on Finance (Article II Agencies): Part II

The Committee gathered to consider Article II agencies (Partial). Invited testimony only. Public testimony on article II will be Wednesday, February 6, 2019. Public testimony will be limited to two minutes. SB 1 Nelson – General Appropriations Bill. Article II –

  • Health and Human Services Health and Human Services Commission
  • Office of Inspector General
  • Texas Civil Commitment Office Department of State Health Services
  • Special Provisions Relating to All Health and Human Services Agencies
This report addresses the Health and Human Services Commission - and presentation material from the Agency - only.
Read more

Texas House of Representatives: Committee on Appropriations

The House Appropriations Committee met to hear testimony on the following:

  • Public Education Funding
  • Medicaid
  • Mental Health
  • School Safety
  • Child Protective Services
  • Border Security Funding
  • Transportation
  • Other budget matters
This report will address the presentations on Medicaid, Mental Health and Child Protective Services only.
Read more

The Weekly Insight: January 28

TEXAS INSIGHT’S RECENT REPORTS Budget/Policy Update on the Cancer Prevention and Research Institute of Texas. The Senate Committee on Finance gathered to discuss select Article I agencies. However, this report…
Read more

HHSC: Drug Utilization Review Board

MEETING SUMMARY Call to order: Roll was called. A quorum was present. Approval of minutes from October 26, 2018: The minutes were approved. New business Public comment on drug classes and therapeutic and clinical drug reviews to be reviewed for the Medicaid Preferred Drug List (PDL):
Read more

“Texas Insight has been a valuable tool that we have utilized both during the
Texas Legislative Session and during the Interim. Timeliness and accuracy are important and that describes
the reporting system. We view it as a very important service to have.”